Multiple Sclerosis
Video
Harold Moses Jr, MD
At the 39th Annual Contemporary Clinical Neurology Symposium, Dr. Moses discusses strategies for remyelination and neuropreservation in multiple...
News
Abatacept fails to provide benefit in relapsing-remitting MS
Conference Coverage
Is Biotin an Effective Treatment for Progressive MS?
News
Hemophilia drugs top Medicaid spending per prescription
Medicaid’s three most expensive drugs by spending per prescription were for treatment of hemophilia, with the cost leader coming in at almost $59,...
News
FDA accepting comments on draft guidelines on compounding law
The Food and Drug Administration is accepting comments on plans to implement a law to restrict compounding of human drug products.
Video
Peter Chin, MD
Dr. Chin discusses the results of several studies presented at the 2016 Annual Meeting of the CMSC that relate to ocrelizumab.
News
Siponimod shows promise through 24 months in relapsing-remitting MS
Key clinical point: Siponimod was associated with sustained efficacy at 24 months among patients with relapsing-remitting multiple sclerosis....
Conference Coverage
Can Stem Cells Halt Progression of MS?
Conference Coverage
Ocrelizumab May Be More Effective for Relapsing-Remitting MS Than Interferon
Conference Coverage
Choosing MS Treatments From the Therapeutic Armamentarium
Video
Frederick Munschauer, MD
At the 2016 CMSC Annual Meeting, Dr. Munschauer discussed the results of three studies that used real-world data to look at relapse rates,...